Teva Expands Central Nervous System (CNS) Development Pipeline with Acquisition of Huntexil® Development Program Rights from NeuroSearch A/S

Posted on February 27, 2015

Posted in Our opinion, Uncategorized, Weekly News
Share Tweet

Share a link